Journals / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 5

COVID-19-related anxiety in phenylketonuria patients

Pages
790–800
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In line with the changing world after the pandemic, different strategies should be considered in the management of patients with inborn errors of metabolism, including PKU

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Phenylketonuria (PKU) is an inherited disorder of amino acid metabolism, the treatment of which often requires a special diet to prevent adverse neuropsychiatric outcomes.
📊
Key Findings & Data:In the COVID-19 pandemic, which has had a substantial effect on the whole world since the beginning of 2020, PKU patients represent a vulnerable population because they may be dependent on special nutritional products, have limited access to routine care and display increased levels of anxiety.
💡
Conclusion & Impact:In line with the changing world after the pandemic, different strategies should be considered in the management of patients with inborn errors of metabolism, including PKU
🔬Design:Survey & Empirical Study
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

Background. Phenylketonuria (PKU) is an inherited disorder of amino acid metabolism, the treatment of which often requires a special diet to prevent adverse neuropsychiatric outcomes. In the COVID-19 pandemic, which has had a substantial effect on the whole world since the beginning of 2020, PKU patients represent a vulnerable population because they may be dependent on special nutritional products, have limited access to routine care and display increased levels of anxiety. Methods. For this reason, an online questionnaire assessing the anxiety levels and various personal opinions and practices regarding the pandemic was sent to the PKU patients managed at our clinic, who were 12 years of age or older. Ninety-eight patients responded to the questionnaire. Median age of the participants was 19 years. Results. Most patients were compliant with the hygiene and social distancing recommendations regarding the spread of COVID-19. Of the patients, 61.2% felt more anxious since the pandemic. The most common concern was the possibility of not being able to obtain special nutritional products (58.2%). Anxiety level was significantly higher in females. Conclusions. These data suggest that food security is an important issue of concern in PKU patients. In line with the changing world after the pandemic, different strategies should be considered in the management of patients with inborn errors of metabolism, including PKU

🔖

Cite This Article

AKAR, H. T., ÇIKI, K., KAHRAMAN, A. B., ERDAL, İ., COŞKUN, T., TOKATLI, A., DURSUN, A., YILDIZ, Y., SİVRİ, H. S., KARABONCUK, Y. (2021). COVID-19-related anxiety in phenylketonuria patients. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 5, 790–800. https://ajindex.com/articles/403046

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet 2010; 376: 1417-1427. 2. van Spronsen F, Huijbregts SC, Bosch AM, Leuzzi V. Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKUpatients: a start toward standardized outcome measurement across development. Mol Genet Metab 2011; 104(Suppl): S45-S51
  2. Ney DM, Gleason ST, van Calcar SC, et al. Nutritional management of PKU with glycomacropeptide from cheese whey. J Inherit Metab Dis 2009; 32: 32-39
  3. Özalp I, Coşkun T, Ceyhan M, et al. Incidence of phenylketonuria and hyperphenylalaninaemia in a sample of the Turkish newborn population. In: Addison GM, Harkness RA, Isherwood DM, Pollit RJ (eds). Practical Developments in Inherited Metabolic Disease: DNA Analysis, Phenylketonuria and Screening for Congenital Adrenal Hyperplasia. Dordrecht: Springer, 1986: 237-239
  4. Özalp I, Coşkun T, Tokatli A, et al. Neonatal PKU screening in Turkey: 7 years experience in a developing country. Screening 1995; 4: 139-147
  5. Tezel B, Dilli D, Bolat H, et al. The development and organization of newborn screening programs in Turkey. J Clin Lab Anal 2014; 28: 63-69
  6. Ozalp I, Coşkun T, Tokatli A, et al. Newborn PKU screening in Turkey: at present and organization for future. Turk J Pediatr 2001; 43: 97-101
  7. Yilmaz Ö. Fenilketonürili bireylerde diyet fenilalanin toleransının değerlendirilmesi. Ankara: Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü, 2017
  8. Abstracts presented at the 13th International Congress of Inborn Errors of Metabolism - ICIEM 2017. J Inborn Errors Metab Screen 2017; 5: 1-413
  9. Wang L, Zou H, Ye F, et al. Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study. J Inherit Metab Dis 2017; 40: 369-376
  10. Eijgelshoven I, Demirdas S, Smith TA, van Loon JM, Latour S, Bosch AM. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands. Mol Genet Metab 2013; 109: 237-242
  11. Gramer G, Haege G, Glahn EM, Hoffmann GF, Lindner M, Burgard P. Living with an inborn error of metabolism detected by newborn screening— parents’ perspectives on child development and impact on family life. J Inherit Metab Dis 2014; 37: 189-195
  12. MacDonald A, Smith TA, de Silva S, Alam V, van Loon JM. The personal burden for caregivers of children with phenylketonuria: a cross-sectional study investigating time burden and costs in the UK. M